Ruxolitinib phosphate cream

DRUG3 trials

Sponsors

Incyte Corporation

Conditions

Alopecia AreataAtopic DermatitisPsoriasis

Phase 1

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

CompletedNCT03257644

Incyte CorporationAtopic Dermatitis

Start: 2017-09-21End: 2020-10-07Updated: 2020-11-10

Phase 2

A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

CompletedNCT00820950

Incyte CorporationPsoriasis

Start: 2007-05-31End: 2009-04-30Updated: 2022-02-08

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

TerminatedNCT02553330

Incyte CorporationAlopecia Areata

Start: 2015-11-18End: 2017-10-03Updated: 2020-12-16

Related Papers

Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis

Annals of Allergy Asthma & Immunology2022-12-2819 citations